Company intelligence / Profile preview

Monarch Alternative Capital

New York, New York, United Statesmonarchlp.com ↗

Ownership: Private
Development stage: Other

Overview

Monarch Alternative Capital is an active global investment firm specializing in opportunistic credit and real estate. It does not develop therapeutics or conduct clinical trials. However, it has invested in healthcare-related real estate assets such as medical office buildings and life science facilities through partnerships but does not itself operate as a life sciences/biotech/pharma/healthcare company

Industry: Investors

Partnerships

Davidson Kempner Capital Management LPCA Ventures

Beyond the preview

Go deeper on Monarch Alternative Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Monarch Alternative Capital.

Explore the full profile